Mode
Text Size
Log in / Sign up
N/A N=58 Treatment

Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System

Head and Neck Neoplasms

Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcome: Primary: The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis. — 54 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Da Vinci Robotic Transoral Robotic Surgical System (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Wake Forest University Health Sciences
Primary completion
Oct 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
The Number and Percent of All Evaluable Patients Who Have Successfully Undergone TORS at Each Interim Analysis.
54
SECONDARY
Operative Time
321
SECONDARY
Number of Participants With Blood Loss and Complications
7
SECONDARY
Average Time to Set up and Perform Procedures
109
SECONDARY
Number of Correctly Predicted Success of TORS Preoperatively
53
SECONDARY
QOL
52

Summary

The purpose of this study is to conduct a pilot single-arm to assess transoral robotic surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci Robotic Surgical System.

Eligibility Criteria

Inclusion Criteria

  • Patient must present with indications for diagnostic or therapeutic approaches for benign and malignant diseases of the oral cavity or laryngopharynx (including the neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate, posterior and lateral pharynx, glottic, supraglottic and subglottic larynx)
  • Patients must have adequate transoral exposure of the oral cavity and laryngopharynx for TORS instrumentation

Exclusion Criteria

  • Unexplained fever and/or untreated, active infection
  • Patient pregnancy
  • Previous head and neck surgery precluding transoral/robotic procedures
  • The presence of medical conditions contraindicating general anesthesia or transoral surgical approaches
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01059357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search